当前位置 肿瘤细胞株 Catlog No. Cell Name Growth Property Morphology Species Disease Organ/Type Subtype Cell Origin Origininal Cat# Growth Medium NGTCBBLA001 1A6 Adherent Epithelial Human Bladder Cancer Bladder ATCC PTA-556 RPMI1640 + 10% FBS NGTCBBLA002 5637 Adherent Epithelial Human Bladder Cancer Bladder ATCC HTB-9 RPMI1640 + 10% FBS NGTCBBLA003 647V Adherent Epithelial Human Bladder Cancer Bladder DSMZ ACC 414 85% Dulbecco's MEM + 15% FBS + 2 mM L-glutamine NGTCBBLA004 97-7 Adherent Epithelial Human Bladder Cancer Bladder COSMIC N/A Ham F12 Nutrient mixture + 1% FBS+ 1% Insulin-Transferrin-Selenium + 1% NEAA +1% L Glutamine + 1ng/ml Hydrocortisone NGTCBBLA005 BFTC-905 Adherent Epithelial Human Bladder Cancer Bladder DSMZ ACC 361 80-90% Dulbecco's MEM + 10-20% h.i. FBS NGTCBBLA006 HT-1197 Adherent Epithelial Human Bladder Cancer Bladder ATCC CRL-1473 MEM + 10% FBS NGTCBBLA007 HT-1376 Adherent Epithelial Human Bladder Cancer Bladder ATCC CRL-1472 MEM + 10% FBS + 1% NEAA NGTCBBLA008 HT1080 Adherent Epithelial Human Bladder Cancer Bladder Fibrosarcoma ECACC 85111505 MEM + 10% FBS + 1% NEAA NGTCBBLA009 J82 Adherent Epithelial Human Bladder Cancer Bladder ATCC HTB-1 MEM + 10% FBS + 1% NEAA + 1% Sodium Pyruvate NGTCBBLA010 KU-19-19 Adherent Epithelial Human Bladder Cancer Bladder DSMZ ACC 395 RPMI1640 + 10% FBS NGTCBBLA011 MGHU3 Adherent Epithelial Human Bladder Cancer Bladder N/A N/A aMEME + 10% FBS NGTCBBLA012 RT112/84 Adherent Epithelial Human Bladder Cancer Bladder ECACC 85061106 MEM + 10% FBS + 1% NEAA NGTCBBLA013 RT4 Adherent Epithelial Human Bladder Cancer Bladder ATCC HTB-2 McCoy's 5a + 10% FBS NGTCBBLA014 SCaBER Adherent Epithelial Human Bladder Cancer Bladder ATCC HTB-3 MEM + 10% FBS + 1% NEAA NGTCBBLA015 SW1710 Adherent Fibroblast Human Bladder Cancer Bladder N/A N/A RPMI1640 + 10% FBS NGTCBBLA016 SW780 Adherent Epithelial Human Bladder Cancer Bladder ATCC CRL-2169 L15 + 10% FBS NGTCBBLA017 T24 Adherent Epithelial Human Bladder Cancer Bladder ATCC HTB-4 RPMI1640 + 10% FBS NGTCBBLA018 TCC-SUP Adherent Epithelial Human Bladder Cancer Bladder DSMZ ACC 377 MEM + 10% FBS + 1% NEAA NGTCBBLA019 UM-UC-3 Adherent Epithelial Human Bladder Cancer Bladder ATCC CRL-1749 MEM + 10% FBS + 1% NEAA + 1% Soudium Pyruvate NGTCBBLA020 VM-CUB-1 Adherent Epithelial Human Bladder Cancer Bladder DSMZ ACC 400 DMEM + 10% FBS NGTCBBON001 MG-63 Adherent Fibroblast Human Bone Osteosarcoma Bladder ATCC CRL-1427 MEM + 10% FBS NGTCBBRA001 T98-G Adherent Fibroblast Human Brain Tumor Brain Glioblastoma multiforme ATCC CRL-1690 MEM + 10% FBS NGTCBBRA002 U-87 MG Adherent Epithelial Human Brain Tumor Brain Glioblastoma; astrocytoma ATCC HTB-14 MEM + 10% FBS NGTCBBRE001 4T1 Adherent Epithelial Mouse Breast Cancer Mammary gland ATCC CRL-2539 RPMI1640 + 10% FBS NGTCBBRE002 BT-20 Adherent Epithelial Human Breast Cancer Mammary gland ATCC HTB-19 DMEM + 10% FBS + 10 ug/ml Insulin NGTCBBRE003 BT-474 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC HTB-20 ATCC Hybri-Care Medium + 1.5 g/L Sodium Bicarbonate + 10% FBS NGTCBBRE004 BT-483 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC HTB-121 DMEM + 20% FBS + 10 ug/ml bovine insulin NGTCBBRE005 BT-549 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC HTB-122 DMEM + 0.23 IU/ml insulin + 10% FBS NGTCBBRE006 CAL-120 Adherent Epithelial Human Breast Cancer Mammary gland DSMZ ACC 459 RPMI1640 + 10% FBS NGTCBBRE007 CAL-51 Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma DSMZ ACC 302 DMEM + 20% FBS NGTCBBRE008 CAMA-1 Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma ATCC HTB-21 MEM + 10% FBS NGTCBBRE009 EFM-192A Adherent Epithelial Human Breast Cancer Mammary gland DSMZ ACC 258 80% RPMI 1640 + 20% h.i. FBS + 2 mM L-glutamine NGTCBBRE010 HCC1143 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-2321 RPMI1640 + 10% FBS NGTCBBRE011 HCC1187 Mixed suspension and adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-2322 RPMI1640 + 10% FBS NGTCBBRE012 HCC1395 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-2324 RPMI1640 + 10% FBS NGTCBBRE013 HCC1419 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-2326 RPMI1640 + 10% FBS NGTCBBRE014 HCC1569 Mixed suspension and adherent Epithelial Human Breast Cancer Mammary gland Metaplastic carcinoma ATCC CRL-2330 RPMI1640 + 10% FBS NGTCBBRE015 HCC1806 Adherent Epithelial Human Breast Cancer Mammary gland Squamous cell carcinoma ATCC CRL-2335 RPMI1640 + 10% FBS NGTCBBRE016 HCC1937 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-2336 RPMI1640 + 10% FBS NGTCBBRE017 HCC1954 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-2338 RPMI1640 + 10% FBS NGTCBBRE018 HCC70 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-2315 RPMI1640 + 10% FBS NGTCBBRE019 Hs 578T Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma ATCC HTB-126 DMEM + 10% FBS +10 ug/ml insulin NGTCBBRE020 JIMT-1 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma DSMZ ACC 589 DMEM + 10% FBS NGTCBBRE021 KPL-4 Adherent Epithelial Human Breast Cancer Mammary gland N/A N/A RPMI 1640 + 10% FBS NGTCBBRE022 MCF 10A Adherent Epithelial Human Fibrocystic disease Mammary gland ATCC CRL-10317 MEBM kit +100 ng/ml cholera toxin NGTCBBRE023 MCF-7/mdr+ Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma N/A N/A DMEM + 10% FBS NGTCBBRE024 MCF7 Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma ATCC HTB-22 DMEM + 10% FBS NGTCBBRE025 MDA-MB-134VI Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC HTB-23 ATCC-formulated Leibovitz's L-15 Medium + 20% FBS NGTCBBRE026 MDA-MB-157 Adherent Epithelial Human Breast Cancer Mammary gland Medulallary carcinoma ATCC HTB-24 L15 + 10% FBS NGTCBBRE027 MDA-MB-175 VII Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC HTB-25 L15 + 20% FBS NGTCBBRE028 MDA-MB-231 Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma ATCC HTB-26 L15 + 10% FBS NGTCBBRE029 MDA-MB-361 Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma ATCC HTB-27 L15 + 10% FBS NGTCBBRE030 MDA-MB-415 Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma ATCC HTB-128 L-15 + 10 ug/ml insulin + 10 ug/ml glutathione + 15% FBS NGTCBBRE031 MDA-MB-436 Adherent Pleomorphic with multinucleated component cells Human Breast Cancer Mammary gland Adenocarcinoma ATCC HTB-130 L-15 + 10 ug/ml insulin+16 ug/ml glutathione+10% FBS NGTCBBRE032 MDA-MB-453 Adherent Epithelial Human Breast Cancer Mammary gland Metastatic carcinoma ATCC HTB-131 L-15 + 10% FBS NGTCBBRE033 MDA-MB-468 Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma ATCC HTB-132 DMEM + 10% FBS NGTCBBRE034 SK-BR-3 Adherent Epithelial Human Breast Cancer Mammary gland Adenocarcinoma ATCC HTB-30 McCoy's 5a + 10% FBS NGTCBBRE035 SUM52PE Adherent Epithelial Human Breast Cancer Mammary gland HAMS F12 + 5% FCS + 5 ug/ml Insulin + 1 ug/ml Hydrocortisone NGTCBBRE036 T-47D Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC HTB-133 DMEM +10% FBS NGTCBBRE037 UACC812 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-1897 L-15 + 20 ng/ml human EGF + 20% FBS NGTCBBRE038 UACC893 Adherent Epithelial Human Breast Cancer Mammary gland ATCC CRL-1902 L15 + 10% FBS NGTCBBRE039 ZR-75-1 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-1500 RPMI1640 + 10% FBS + 10ug/ml insuline NGTCBBRE040 ZR-75-30 Adherent Epithelial Human Breast Cancer Mammary gland Ductal Carcinoma ATCC CRL-1504 RPMI1640 + 10% FBS NGTCBCER001 Hela Adherent Epithelial Human Cervical Carcinoma Cervix RPMI1640 + 10% FBS NGTCBCER002 ME 180 Adherent Epithelial Human Cervical Carcinoma Cervix RPMI1640 + 10% FBS NGTCBCOL001 BE Adherent Epithelial Human Colorectal Cancer Colon DMEM + 10% FBS NGTCBCOL002 C-75 Adherent Epithelial Human Colorectal Cancer Colon IMDM + 10% FBS (Incubate at 10% CO2) NGTCBCOL003 C-99 Adherent Epithelial Human Colorectal Cancer Colon IMDM + 10% FBS (Incubate at 10% CO2) NGTCBCOL004 CC-20 Adherent Epithelial Human Colorectal Cancer Colon DMEM + 10% FBS (Incubate at 10% CO2) NGTCBCOL005 CCK-81 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma JCRB JCRB0208 DMEM + 10% FBS (Incubate at 10% CO2) NGTCBCOL006 COLO 205 Mixed suspension and adherent Epithelial Human Colorectal Cancer Colon Dukes/ type D ATCC CCL-222 DMEM + 10% FBS NGTCBCOL007 COLO 320DM Mixed suspension and adherent Epithelial Human Colorectal Cancer Colon Dukes/ type C ATCC CCL-220 RPMI1640 + 10% FBS NGTCBCOL008 CaCO2 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Grade II ECACC 86010202 DMEM + 10% FBS NGTCBCOL009 HCA-7 Adherent Epithelial Human Colorectal Cancer Colon Dukes/ type B ECACC 6061902 DMEM + 10% FBS (Incubate at 10% CO2) NGTCBCOL010 HCT 116 Adherent Epithelial Human Colorectal Cancer Colon ATCC CCL-247 McCoy's 5a +10% FBS NGTCBCOL011 HCT-15 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes' type C ATCC CCL-225 RPMI1640 + 10% FBS NGTCBCOL012 HCT-8 Adherent Epithelial Human Colorectal Cancer Colon Ileocecal colorectal adenocarcinoma ATCC CCL-244 RPMI1640 + 10% FBS NGTCBCOL013 HRA-19 Adherent Epithelial Human Colorectal Cancer Colon IMDM + 10% FBS (Incubate at 10% CO2) NGTCBCOL014 HT29 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma ATCC HTB-38 RPMI1640 + 10% FBS NGTCBCOL015 LOVO Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes type C, grade IV ATCC CCL-229 DMEM + 10% FBS NGTCBCOL016 LS 180 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes type B ATCC CL-187 MEM + 10% FBS NGTCBCOL017 LS1034 Adherent Epithelial Human Colorectal Cancer Cecum Dukes type C ATCC CRL-2158 RPMI1640 + 10% FBS NGTCBCOL018 LS174T Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes' type B ATCC CL-188 RPMI1640 + 10% FBS NGTCBCOL019 RKO Adherent Epithelial Human Colorectal Cancer Colon ATCC CRL-2577 MEM + 10% FBS NGTCBCOL020 SK-CO-1 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma ATCC HTB-39 MEM + 10% FBS NGTCBCOL021 SL4 Adherent Epithelial Human Colorectal Cancer Colon RPMI1640 + 10% FBS NGTCBCOL022 SNU-1040 Adherent Epithelial Human Colorectal Cancer Colon RPMI1640 + 300 mg/L L-glutamine + 25 mM HEPES + 25 mM NaHCO3 +10% hiFBS NGTCBCOL023 SNU-407 Adherent Epithelial Human Colorectal Cancer Colon RPMI1640 + 300 mg/L L-glutamine + 25 mM HEPES + 25 mM NaHCO3 +10% hiFBS NGTCBCOL024 SW1417 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes type C, grade III ATCC CCL-238 L-15 + 10% FBS NGTCBCOL025 SW403 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes type C, grade III ATCC CCL-230 L-15 + 10% FBS NGTCBCOL026 SW48 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes type C, grade IV ATCC CCL-231 L-15 + 10% FBS NGTCBCOL027 SW480 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes' type B ATCC CCL-228 L-15 + 10% FBS NGTCBCOL028 SW620 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes' type C ATCC CCL-227 L-15 + 10% FBS NGTCBCOL029 SW948 Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma, Dukes type C, grade III ATCC CCL-237 L-15 + 10% FBS NGTCBCOL030 WIDR Adherent Epithelial Human Colorectal Cancer Colon Adenocarcinoma ATCC CCL-218 MEM + 10% FBS NGTCBEND001 AN3CA Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma ATCC HTB-111 MEM + 10% FBS NGTCBEND002 EFE-184 Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma DSMZ ACC 230 RPMI1640:MEM (1:1) + 20% FBS + 10 ug/ml insulin NGTCBEND003 EN Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma RPMI1640 + 10% FBS NGTCBEND004 HEC-1-A Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma ATCC HTB-112 McCoy's 5a +10% FBS NGTCBEND005 HEC-1-B Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma ATCC HTB-113 MEM + 10% FBS NGTCBEND006 KLE Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma RPMI1640 + 10% FBS NGTCBEND007 MFE-280 Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma ECACC 98050131 40% RPMI1640 + 40% MEM + 20% FBS + 1x insulin-transferrin-sodium selenite NGTCBEND008 MFE-296 Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma ECACC 98031101 MEM + 10% FBS NGTCBEND009 RL95-2 Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma MEM + 10% FBS NGTCBEND010 SK-UT-1 Adherent Epithelial Human Endometrial Carcinoma Uterus Mesodermal tumor (mixed), Grade III ATCC HTB-114 MEM + 10% FBS NGTCBEND011 SK-UT-1B Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Mesodermal tumor (mixed), Grade III ATCC HTB-115 MEM + 10% FBS NGTCBEND012 SNG-M Adherent Epithelial Human Endometrial Carcinoma Uterine endometrium Adenocarcinoma JCRB IF050313 F12 + 10% FBS NGTCBESO001 Bic-1 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO002 Colo-680N Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma DSMZ ACC 182 RPMI1640 + 10% FBS NGTCBESO003 EC9706 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO004 ECa 109 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO005 KYSE140 Adherent Fibroblast Human Esophageal Cancer Esophagus Squamous cell carcinoma DSMZ ACC 348 RPMI1640 + 10% FBS NGTCBESO006 KYSE180 Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma JCRB JCRB1093 RPMI1640 + 10% FBS NGTCBESO007 KYSE30 Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma ECACC 94072011 RPMI1640 + 10% FBS NGTCBESO008 KYSE450 Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma DSMZ ACC 387 RPMI1640 + 10% FBS NGTCBESO009 KYSE510 Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma DSMZ ACC 374 RPMI1640 + 10% FBS NGTCBESO010 KYSE70 Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma ECACC 94072012 RPMI1640 + 10% FBS NGTCBESO011 OACP4C Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO012 SKGT4 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO013 Seg1 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO014 T.T Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma JCRB JCRB0262 DMEM/F12 (1:1) + 10% FBS NGTCBESO015 T.Tn Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma JCRB JCRB0261 DMEM/F12 (1:1) + 10% FBS NGTCBESO016 TE-15 Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma RCB RCB1951 RPMI1640 + 10% FBS NGTCBESO017 TE-4 Adherent Epithelial Human Esophageal Cancer Esophagus Squamous cell carcinoma RCB RCB2097 RPMI1640 + 10% FBS NGTCBESO018 TE10 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO019 TE12 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO020 TE3 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO021 TE7 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBESO022 Yes2 Adherent Epithelial Human Esophageal Cancer Esophagus RPMI1640 + 10% FBS NGTCBGAS001 23132/87 Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma DSMZ ACC 201 RPMI1640 + 10% FBS NGTCBGAS002 AGS Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma ATCC CRL-1739 RPMI1640 + 10% FBS NGTCBGAS003 AZ-521 Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB0061 RPMI1640 + 10% FBS NGTCBGAS004 BGC-823 Adherent Epithelial Human Gastric Cancer Stomach RPMI1640 + 10% FBS NGTCBGAS005 FU97 Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma JCRB JCRB1074 RPMI1640 + 10% FBS NGTCBGAS006 GTL16 Adherent Epithelial Human Gastric Cancer Stomach RPMI1640 + 10% FBS NGTCBGAS007 HGC27 Adherent Epithelial Human Gastric Cancer Stomach ECACC 94042256 RPMI1640 + 10% FBS NGTCBGAS008 HS746T Adherent Epithelial Human Gastric Cancer Stomach ATCC HTB-135 DMEM + 10% FBS + 1% NEAA + 1% Sodium Pyruvate NGTCBGAS009 IM95 Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB1075.0 DMEM + 10% FBS + 10 ug/ml insulin NGTCBGAS010 KATO III Mixed suspension and adherent Epithelial Human Gastric Cancer Stomach ATCC HTB-103 RPMI1640 + 10% FBS NGTCBGAS011 KE-39 Adherent Epithelial Human Gastric Cancer Stomach RCB RCB1434 RPMI1640 + 10% FBS NGTCBGAS012 MGC803 Adherent Epithelial Human Gastric Cancer Stomach RPMI1640 + 10% FBS NGTCBGAS013 MKN1 Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB0252 RPMI1640 + 10% FBS NGTCBGAS014 MKN28 Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB0253 RPMI1640 + 10% FBS NGTCBGAS015 MKN45 Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB0254 RPMI1640 + 10% FBS NGTCBGAS016 MKN7 Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB1025 RPMI1640 + 10% FBS NGTCBGAS017 MKN74 Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma JCRB JCRB0254 RPMI1640 + 10% FBS NGTCBGAS018 NCI-N87 Adherent Epithelial Human Gastric Cancer Stomach ATCC CRL-5822 RPMI1640 + 10% FBS NGTCBGAS019 NUGC-2 Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB0821 RPMI1640 + 10% FBS NGTCBGAS020 NUGC-3 Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB0822 RPMI1640 + 10% FBS NGTCBGAS021 NUGC-4 Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB0834 RPMI1640 + 10% FBS NGTCBGAS022 OCUM-1 Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma JCRB JCRB0192 DMEM + 1% Soudium Pyruvate + 10% FBS NGTCBGAS023 OE19 Adherent Epithelial Human Gastric Cancer Oesophagus/gastric cardia ECACC 96071721 RPMI1640 + 10% FBS NGTCBGAS024 OE33 Adherent Epithelial Human Gastric Cancer Oesophagus ECACC 96070808 RPMI1640 + 10% FBS NGTCBGAS025 PAMC82 Adherent Epithelial Human Gastric Cancer Stomach RPMI1640 + 10% FBS NGTCBGAS026 PHM82 Adherent Epithelial Human Gastric Cancer Stomach RPMI1640 + 10% FBS NGTCBGAS027 SCH Adherent Epithelial Human Gastric Cancer Stomach JCRB JCRB0251 RPMI1640 + 10% FBS NGTCBGAS028 SGC7901 Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma RPMI1640 + 10% FBS NGTCBGAS029 SNU-1 Suspension Epithelial Human Gastric Cancer Stomach ATCC CRL-5971 RPMI1640 + 10% FBS NGTCBGAS030 SNU-16 Suspension Epithelial Human Gastric Cancer Stomach ATCC CRL-5974 RPMI1640 + 10% FBS NGTCBGAS031 SNU-216 Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma KCLB 216 RPMI1640 + 10% FBS NGTCBGAS032 SNU-484 Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma KCLB 484 RPMI1640 + 10% FBS NGTCBGAS033 SNU-5 Suspension Epithelial Human Gastric Cancer Stomach ATCC CRL-5973 RPMI1640 + 10% FBS NGTCBGAS034 SNU-520 Suspension Epithelial Human Gastric Cancer Stomach Adenocarcinoma KCLB 520 RPMI1640 + 10% FBS NGTCBGAS035 SNU-601 Adherent Epithelial Human Gastric Cancer Stomach signet ring cell KCLB 601 RPMI1640 + 10% FBS NGTCBGAS036 SNU-620 Suspension Epithelial Human Gastric Cancer Stomach Adenocarcinoma KCLB 620 RPMI1640 + 10% FBS NGTCBGAS037 SNU-638 Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma KCLB 638 RPMI1640 + 10% FBS NGTCBGAS038 SNU-668 Adherent Epithelial Human Gastric Cancer Stomach signet ring cell KCLB 668 RPMI1640 + 10% FBS NGTCBGAS039 SNU-719 Adherent Epithelial Human Gastric Cancer Stomach Adenocarcinoma KCLB 719 RPMI1640 + 10% FBS NGTCBHEP001 BEL7402 Adherent Epithelial Human Hepatocellular Carcinoma Liver SIMM RPMI1640 + 10% FBS NGTCBHEP002 BEL7404 Adherent Epithelial Human Hepatocellular Carcinoma Liver SIBS RPMI1640 + 10% FBS NGTCBHEP003 BEL7405 Adherent Epithelial Human Hepatocellular Carcinoma Liver SIBS RPMI1640 + 10% FBS NGTCBHEP004 H22 Suspension Epithelial Mouse Hepatocellular Carcinoma Liver CCTCC RPMI1640 + 10% FBS NGTCBHEP005 HCCLM3 Adherent Epithelial Human Hepatocellular Carcinoma Liver SIBS RPMI1640 + 10% FBS NGTCBHEP006 HCCLM6 Adherent Epithelial Human Hepatocellular Carcinoma Liver SIBS DMEM + 10% FBS NGTCBHEP007 HLE Adherent Epithelial Human Hepatocellular Carcinoma Liver JCRB JCRB0404 DMEM + 10% FBS NGTCBHEP008 HLF Adherent Epithelial Human Hepatocellular Carcinoma Liver JCRB JCRB0405 DMEM + 5% FBS NGTCBHEP009 Hep3B Adherent Epithelial Human Hepatocellular Carcinoma Liver ATCC HB-8064 MEM + 10% FBS NGTCBHEP010 HepG2 Adherent Epithelial Human Hepatocellular Carcinoma Liver ATCC HB-8065 RPMI1640 + 10% FBS NGTCBHEP011 HuH-1 Adherent Epithelial Human Hepatocellular Carcinoma Liver JCRB JCRB0199 DMEM + 10% FBS NGTCBHEP012 HuH-7 Adherent Epithelial Human Hepatocellular Carcinoma Liver JCRB JCRB0403 DMEM + 10% FBS NGTCBHEP013 MHCC97 Adherent Epithelial Human Hepatocellular Carcinoma Liver DMEM + 10% FBS NGTCBHEP014 McA-RH7777 Adherent Epithelial Rat Hepatocellular Carcinoma Liver ATCC CRL-1601 DMEM + 10% FBS NGTCBHEP015 PLC/PRF/5 Adherent Epithelial Human Hepatocellular Carcinoma Liver ATCC CRL-8024 RPMI1640 + 10% FBS NGTCBHEP016 QGY7701 Adherent Epithelial Human Hepatocellular Carcinoma Liver SIBS RPMI1640 + 10% FBS NGTCBHEP017 QGY7703 Adherent Epithelial Human Hepatocellular Carcinoma Liver SIBS DMEM + 10% FBS NGTCBHEP018 SK-HEP-1 Adherent Epithelial Human Hepatocellular Carcinoma Liver Adenocarcinoma ATCC HTB-52 RPMI1640 + 10% FBS NGTCBHEP019 SMMC-7721 Adherent Epithelial Human Hepatocellular Carcinoma Liver SIMM RPMI1640 + 10% FBS NGTCBHEP020 SNU-182 Adherent Epithelial Human Hepatocellular Carcinoma Liver Grade III/IV ATCC CRL-2235 RPMI1640 + 10% FBS NGTCBHEP021 SNU-354 Adherent Polygonal Human Hepatocellular Carcinoma Liver Grade II-III/IV KCLB 354 RPMI1640 + 10% FBS NGTCBHEP022 SNU-368 Adherent Polygonal Human Hepatocellular Carcinoma Liver Grade II-IV/IV KCLB 368 RPMI1640 + 10% FBS NGTCBHEP023 SNU-387 Adherent Epithelial Human Hepatocellular Carcinoma Liver Grade IV/V ATCC CRL-2237 RPMI1640 + 10% FBS NGTCBHEP024 SNU-398 Mixed suspension and adherent Epithelial Human Hepatocellular Carcinoma Liver ATCC CRL-2233 RPMI1640 + 10% FBS NGTCBHEP025 SNU-423 Adherent Epithelial Human Hepatocellular Carcinoma Liver Grade III/IV ATCC CRL-2238 RPMI1640 + 10% FBS NGTCBHEP026 SNU-449 Adherent Epithelial Human Hepatocellular Carcinoma Liver Grade II-III/IV ATCC CRL-2234 RPMI1640 + 10% FBS NGTCBHEP027 SNU-475 Adherent Epithelial Human Hepatocellular Carcinoma Liver Grade II-IV/IV ATCC CRL-2236 RPMI1640 + 10% FBS NGTCBHEP028 SNU-739 Adherent Spindle Human Hepatocellular Carcinoma Liver KCLB 739 RPMI1640 + 10% FBS NGTCBHEP029 SNU-761 Adherent Polygonal Human Hepatocellular Carcinoma Liver KCLB 761 RPMI1640 + 10% FBS NGTCBHEP030 SNU-878 Adherent Epithelial Human Hepatocellular Carcinoma Liver KCLB 878 RPMI1640 + 10% FBS NGTCBHEP031 SNU-886 Adherent Polygonal Human Hepatocellular Carcinoma Liver KCLB 886 RPMI1640 + 10% FBS NGTCBHEP032 Zip-177 Adherent Epithelial Mouse Hepatocellular Carcinoma Liver SIMM RPMI1640 + 10% FBS NGTCBCHO001 HCCC9810 Adherent Epithelial Human Intra-Cholangiocarcinoma Bile duct SIBS DMEM + 10% FBS NGTCBKID001 786-O Adherent Epithelial Human Kidney Cancer Kidney Renal cell adenocarcinoma ATCC CRL-1932 RPMI1640 + 10% FBS Caki-1 Adherent Epithelial Human Kidney Cancer Kidney Clear cell carcinoma ATCC HTB-46 McCoy's 5a +10% FBS NGTCBLEU001 AMO-1 Suspension Round cell Human Leukemia Blood Plasmacytoma DSMZ ACC 538 RPMI1640 +20% FBS NGTCBLEU002 ARH-77 Suspension Round cell Human Leukemia Blood Plasma cell leukemia ATCC ACRL-1621 RPMI1640 + 10% FBS NGTCBLEU003 CMK Suspension Round cell Human Leukemia Blood Acute megakaryocytic leukemia DSMZ ACC 392 80-90% RPMI 1640 + 10-20% FBS NGTCBLEU004 HEL 92.1.7 Suspension Round cell Human Leukemia Blood Erythroleukemia ATCC TIB-180 RPMI1640 + 10% FBS NGTCBLEU005 HL60 Suspension Round cell Human Leukemia Blood Acute promyelocytic leukemia ATCC CCL-240 RPMI1640 + 10% FBS NGTCBLEU006 JURKAT Suspension Round cell Human Leukemia Blood Plasma cell leukemia DSMZ ACC 282 DMEM/IMDM(1:1) + 20% FBS NGTCBLEU007 JVM 3 Suspension Round cell Human Leukemia Blood Chronic B cell leukemia DSMZ ACC 18 RPMI1640 + 10% FBS NGTCBLEU008 K-562 Suspension Round cell Human Leukemia Blood Plasma cell leukemia DSMZ ACC 541 DMEM/IMDM(1:1) + 20% FBS NGTCBLEU009 KG-1 Suspension Round cell Human Leukemia Blood Acute myelogenous leukemia ATCC CCL-246 IMDM + 20% FBS NGTCBLEU010 L-363 Suspension Round cell Human Leukemia Blood Plasma cell leukemia DSMZ ACC 49 85% RPMI 1640 + 15% FBS NGTCBLEU011 MEC-1 Suspension Round cell Human Leukemia Blood Chronic B cell leukemia DSMZ ACC 497 IMDM + 10% FBS NGTCBLEU012 MOLM-13 Suspension Round cell Human Leukemia Blood Human acute myeloid leukemia DSMZ ACC 554 RPMI1640 + 10% FBS NGTCBLEU013 MOLM-16 Suspension Round cell Human Leukemia Blood Human acute myeloid leukemia DSMZ ACC 555 60-65% RPMI 1640 + 20% FBS + 15-20% vol conditioned medium of cell line 5637 NGTCBLEU014 MV-4-11 Suspension Round cell Human Leukemia Blood Myelomonocytic ATCC CRL-9591 IMDM + 10% FBS NGTCBLEU015 MonoMac6 Suspension Round cell Human Leukemia Blood Human acute monocytic leukemia DSMZ ACC 124 RPMI 1640 + 10% FBS + NEAA + 1 mM sodium pyruvate + 10 ug¸/ml human insulin NGTCBLEU016 NOMO-1 Suspension Round cell Human Leukemia Blood Human acute myeloid leukemia DSMZ ACC 542 RPMI1640 + 10% FBS NGTCBLEU017 OCI-AML2 Suspension Round cell Human Leukemia Blood Human acute myeloid leukemia DSMZ ACC 99 80-90% alpha-MEM + 10-20% FBS NGTCBLEU018 OCI-AML5 Suspension Round cell Human Leukemia Blood Human acute myeloid leukemia DSMZ ACC 247 70% alpha-MEM + 20% FBS + 10% vol conditioned medium of cell line 5637   NGTCBLEU019 OCI-M2 Suspension Round cell Human Leukemia Blood Leukemia RPMI1640 + 10% FBS NGTCBLEU020 RAW264.7 Adherent Round cell Mouse Leukemia Blood Abelson murine leukemia virus-induced tumor DMEM + 10% FBS NGTCBLEU021 RS4;11 Suspension Round cell Human Leukemia Blood Acute lymphoblastic leukemia RPMI1640 + 10% FBS NGTCBLEU022 Reh Suspension Round cell Human Leukemia Blood Acute Llymphocytic leukemia ATCC CRL-8286 RPMI1640 + 10% FBS NGTCBLEU023 THP-1 Suspension Round cell Human Leukemia Blood Acute monocytic leukemia ATCC TIB-202 RPMI1640 + 10% FBS NGTCBLEU024 WEHI-3 Suspension Round cell Mouse Leukemia Blood Leukemia ATCC TIB-68 IMDM + 10% FBS NGTCBLUN001 95-D Adherent Epithelial Human Lung Cancer Lung Adenocarcinoma RPMI1640 + 10% FBS NGTCBLUN002 A549 Adherent Epithelial Human Lung Cancer Lung ATCC CCL-185 RPMI1640 + 10% FBS NGTCBLUN003 Calu-1 Adherent Epithelial Human Lung Cancer Lung Epidermoid carcinoma, Grade III ATCC HTB-54 RPMI1640 + 10% FBS NGTCBLUN004 Calu-3 Adherent Epithelial Human Lung Cancer Lung Adenocarcinoma ATCC HTB-55 MEM + 10% FBS NGTCBLUN005 Calu-6 Adherent Epithelial Human Lung Cancer Lung Anaplastic carcinoma ATCC HTB-56 RPMI1640 + 10% FBS NGTCBLUN006 DMS 114 Adherent Epithelial Human Lung Cancer Lung Small cell lung cancer ATCC CRL-2066 RPMI1640 + 10% FBS NGTCBLUN007 DMS 53 Adherent Epithelial Human Lung Cancer Lung Small cell lung cancer ECACC 95062823 Waymouth's MB 752/1 + 2mM Glutamine + 10% H.I. FBS NGTCBLUN008 EBC-1 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma JCRB JCRB0820 MEM + 10% FBS NGTCBLUN009 GLC15 Adherent Epithelial Human Lung Cancer Lung RPMI1640 + 10% FBS NGTCBLUN010 HAC-84 Adherent Epithelial Human Lung Cancer Lung RPMI1640 + 10% FBS NGTCBLUN011 HARA Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma JCRB JCRB1080.0 RPMI1640 + 10% FBS NGTCBLUN012 HARA-B Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma JCRB JCRB1080.1 RPMI1640 + 10% FBS NGTCBLUN013 HCC-1195 Adherent Epithelial Human Lung Cancer Lung Adeno-squamous cell carcinoma KCLB 71195 RPMI1640 + 10% FBS NGTCBLUN014 HCC-15 Adherent Epithelial Human Lung Cancer Lung NSCLC KCLB 70015 RPMI1640 + 10% FBS NGTCBLUN015 HCC-1588 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma KCLB 71588 RPMI1640 + 10% FBS NGTCBLUN016 HCC-2279 Adherent Epithelial Human Lung Cancer Lung Adeno-squamous cell carcinoma KCLB 72279 RPMI1640 + 10% FBS NGTCBLUN017 HCC-366 Adherent Epithelial Human Lung Cancer Lung Adeno-squamous cell carcinoma KCLB 70366 RPMI1640 + 10% FBS NGTCBLUN018 HCC-78 Adherent Epithelial Human Lung Cancer Lung NSCLC DSMZ ACC 563 RPMI1640 + 10% FBS NGTCBLUN019 HCC-95 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma KCLB 70095 RPMI1640 + 10% FBS NGTCBLUN020 HCC827 Adherent Epithelial Human Lung Cancer Lung Adenocarcinoma ATCC CRL-2868 RPMI1640 + 10% FBS NGTCBLUN021 HX 147 Adherent Epithelial Human Lung Cancer Lung Large cell lung carcinoma F12 + 10% FBS NGTCBLUN022 KNS-62 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma MEM + 10% FBS NGTCBLUN023 L115 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma RPMI1640 + 10% FBS + 1% Sodium Pyruvate + 1% NEAA NGTCBLUN024 LC-1 sq Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma JCRB JCRB0258 RPMI1640/F12(1:1 ) + 10% FBS NGTCBLUN025 LC-2/ad Adherent Epithelial Human Lung Cancer Lung Adenocarcinoma ECACC 94072247 RPMI 1640:HAMS F12 (1:1) + 2mM Glutamine + 10% FBS NGTCBLUN026 LK-2 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma JCRB JCRB0829 RPMI1640 + 10% FBS NGTCBLUN027 LOU-NH91 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma DSMZ ACC 393 RPMI1640 + 20% H.I. FBS NGTCBLUN028 LUDLU-1 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma ECACC 92012463 RPMI1640 + 10% FBS NGTCBLUN029 NCI-H1299 Adherent Epithelial Human Lung Cancer Lung NSCLC ATCC CRL-5803 RPMI1640 + 10% FBS NGTCBLUN030 NCI-H1385 Suspension Epithelial Human Lung Cancer Lung NSCLC, Stage IIIA ATCC CRL-5867 RPMI1640 + 10% FBS NGTCBLUN031 NCI-H1417 Suspension Epithelial Human Lung Cancer Lung Small cell lung cancer ATCC CRL-5869 RPMI1640 + 1mM soodium Pyruvate + 2.5 g/L Glucose +10% FBS NGTCBLUN032 NCI-H1437 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma, Stage I ATCC CRL-5872 RPMI1640 + 10% FBS NGTCBLUN033 NCI-H1648 Adherent Epithelial Human Lung Cancer Lung Adenocarcinoma, Stage IIIA ATCC CRL-5882 BEGM kit +10% FBS NGTCBLUN034 NCI-H1650 Adherent Epithelial Human Lung Cancer Lung Adenocarcinoma, Stage IIIB ATCC CRL-5883 RPMI1640 + 10% FBS NGTCBLUN035 NCI-H1688 Adherent Epithelial Human Lung Cancer Lung Small cell lung cancer ATCC CCL-257 RPMI1640 + 10% FBS NGTCBLUN036 NCI-H1703 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma, Stage I ATCC CRL-5889 RPMI1640 + 10% FBS NGTCBLUN037 NCI-H1781 Adherent Epithelial Human Lung Cancer Lung Adenocarcinoma, Stage IIIB ATCC CRL-5894 RPMI1640 + 10% FBS NGTCBLUN038 NCI-H1793 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma ATCC CRL-5896 BEGM kit +10%FBS NGTCBLUN039 NCI-H1869 Adherent Epithelial Human Lung Cancer Lung NSCLC, Stage IV ATCC CRL-5900 BEGM kit +10%FBS NGTCBLUN040 NCI-H196 Adherent Epithelial Human Lung Cancer Lung Small cell lung cancer ATCC CRL-5823 RPMI1640 + 10% FBS NGTCBLUN041 NCI-H1975 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma ATCC CRL-5908 RPMI1640 + 10% FBS NGTCBLUN042 NCI-H1993 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma, Stage IIIA ATCC CRL-5909 BEGM kit +10%FBS NGTCBLUN043 NCI-H2066 Adherent Epithelial Human Lung Cancer Lung Mixed, adenocarcinoma, squamouse cell carcinoma ATCC CRL-5917 DMEM:F12 + 0.01 mg/ml Transferrin + 30 nM Sodium selenite + 10 nM Hydrocortisone + 10 nM beta-estradiol + 2 mM L-glutamine + 5% FBS NGTCBLUN044 NCI-H2085 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma ATCC CRL-5921 BEGM kit +10%FBS NGTCBLUN045 NCI-H2122 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma, Stage IV ATCC CRL-5985 RPMI1640 + 10% FBS NGTCBLUN046 NCI-H2126 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma ATCC CCL-256 BEGM kit +10%FBS NGTCBLUN047 NCI-H2170 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma ATCC CRL-5928 RPMI1640 + 10% FBS NGTCBLUN048 NCI-H2228 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma ATCC CRL-5935 RPMI1640 + 10% FBS NGTCBLUN049 NCI-H226 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma ATCC CRL-5826 RPMI1640 + 10% FBS NGTCBLUN050 NCI-H2286 Adherent Epithelial Human Lung Cancer Lung Small cell lung cancer, mixed adenocarcinoma and squamous cell carcinoma, Stage I ATCC CRL-5938 BEGM kit +10%FBS NGTCBLUN051 NCI-H2291 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma ATCC CRL-5939 DMEM + 10% FBS NGTCBLUN052 NCI-H23 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma ATCC CRL-5800 RPMI1640 + 10% FBS NGTCBLUN053 NCI-H3122 Adherent Epithelial Human Lung Cancer Lung NSCLC ATCC CRL-5803 RPMI1640 + 10% FBS NGTCBLUN054 NCI-H322 Adherent Epithelial Human Lung Cancer Lung Bronchioalveolar carcinoma ECACC 95111734 RPMI1640 + 10% FBS NGTCBLUN055 NCI-H3255 Adherent Epithelial Human Lung Cancer Lung NSCLC ATCC CRL-2882 BEGM kit +10%FBS NGTCBLUN056 NCI-H358 Adherent Epithelial Human Lung Cancer Lung NSCLC ATCC CRL-5807 RPMI1640 + 10% FBS NGTCBLUN057 NCI-H441 Adherent Epithelial Human Lung Cancer Lung Papillary adenocarcinoma ATCC HTB-174 RPMI1640 + 10% FBS NGTCBLUN058 NCI-H460 Adherent Epithelial Human Lung Cancer Lung Large cell lung carcinoma ATCC HTB-177 RPMI1640 + 10% FBS NGTCBLUN059 NCI-H520 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma ATCC HTB-182 RPMI1640 + 10% FBS NGTCBLUN060 NCI-H522 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma, Stage II ATCC CRL-5810 RPMI1640 + 10% FBS NGTCBLUN061 NCI-H526 Suspension Epithelial Human Lung Cancer Lung Variant small cell lung cancer, Stage E ATCC CRL-5811 RPMI1640 + 10% FBS NGTCBLUN062 NCI-H596 Adherent Epithelial Human Lung Cancer Lung Adenosquamous carcinoma ATCC HTB-178 RPMI1640 + 10% FBS NGTCBLUN063 NCI-H647 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenosquamous carcinoma, Stage IIIA ATCC CRL-5834 RPMI1640 + 10% FBS NGTCBLUN064 NCI-H810 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma, Stage II ATCC CRL-5816 BEGM kit +10%FBS NGTCBLUN065 NCI-H838 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma, Stage IIIB ATCC CRL-5844 RPMI1640 + 10% FBS NGTCBLUN066 NCI-H889 Suspension Floating aggregates Human Lung Cancer Lung Small cell lung cancer, Stage E ATCC CRL-5817 RPMI1640 + 10% FBS NGTCBLUN067 Oka-C-1 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma JCRB JCRB1343 RPMI1640 + 10% FBS NGTCBLUN068 PC-9 Adherent Epithelial Human Lung Cancer Lung NSCLC RPMI1640 + 10% FBS NGTCBLUN069 PC14PE6 Mixed suspension and adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma DMEM + 10% FBS NGTCBLUN070 RERF-LC-AI Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma RIKEN RCB0444 MEM + 10% FBS NGTCBLUN071 RERF-LC-Sq1 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma JCRB JCRB1019 RPMI1640 + 10% FBS NGTCBLUN072 SHP-77 Loosely adherent Floating aggregates Human Lung Cancer Lung Small cell lung cancer ATCC CRL-2195 RPMI1640 + 10% FBS NGTCBLUN073 SK-MES-1 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma KCLB 30058 RPMI1640 + 10% FBS NGTCBLUN074 SPC-A1 Adherent Epithelial Human Lung Cancer Lung NSCLC, Adenocarcinoma RPMI1640 + 10% FBS NGTCBLUN075 SW1573 Adherent Epithelial Human Lung Cancer Lung Alveolar cell carcinoma ATCC CRL-2170 L15 + 10% FBS NGTCBLUN076 SW1271 Adherent Epithelial Human Lung Cancer Lung Small cell lung cancer ATCC CRL-2177 L15 + 10% FBS NGTCBLUN077 SW900 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma, Grade IV ATCC HTB-59 RPMI1640 + 10% FBS NGTCBLUN078 VMRC-LCP Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma JCRB JCRB0103 MEM + 1% NEAA + 10% FBS NGTCBLUN079 YTMLC-90 Adherent Epithelial Human Lung Cancer Lung Squamous cell carcinoma RPMI1640 + 10% FBS NGTCBLYM001 JEKO-1 Suspension Lymphoblast Human Lymphoma Blood Mantle Cell Lymphoma ATCC CRL-3006 RPMI1640 + 20% FBS NGTCBLYM002 NAMALWA Suspension Lymphoblast Human Lymphoma B Lymphocyte Burkitt's Lymphoma ATCC CRL-1432 RPMI1640 + 10% FBS NGTCBLYM003 NK-92 Suspension Lymphoblast Human Lymphoma Natural killer cell Non-Hodgkin's Lymphoma ATCC CRL-2407 Alpha-MEM + 2 mM L-glutamine + 1.5 g/L sodium bicarbonate + 0.2 mM inositol + 0.1 mM 2-mercaptoethanol + 0.02 mM folic acid + 100-200 U/ml recombinant IL-2 + 12.5% horse serum + 12.5% FBS NGTCBLYM004 OCI-LY-19 Suspension Lymphoblast Human Lymphoma Bone marrow B cell lymphoma DSMZ ACC 528 80-90% alpha-MEM + 10-20% FBS NGTCBLYM005 Raji Suspension Epithelial Human Lymphoma B Lymphocyte Burkitt's Lymphoma ATCC CCL-86 RPMI1640 + 10% FBS NGTCBLYM006 Ramos (RA1) Suspension Lymphoblast Human Lymphoma B Lymphocyte Burkitt's Lymphoma ATCC CRL-1596 RPMI1640 + 10% FBS NGTCBLYM007 SC-1 Suspension Lymphoblast Human Lymphoma B Lymphocyte B cell lymphoma ATCC CRL-8756 RPMI1640 + 10% FBS NGTCBLYM008 U-937 Suspension Lymphoblast Human Lymphoma Lymphocyte Histiocytic lymphoma ATCC CRL-1593.2 RPMI1640 + 10% FBS NGTCBLYM009 WSU DLCL2 Suspension Lymphoblast Human Lymphoma B Lymphocyte B-cell Non-Hodgkin's Lymphoma DSMZ ACC 575 RPMI1640 + 10% FBS NGTCBMEL001 A-375 Adherent Epithelial Human Malignant melanoma Skin Malignant melanoma ATCC CRL-1619 DMEM + 10% FBS NGTCBMEL002 A2058 Adherent Epithelial Human Malignant melanoma Skin Malignant melanoma ATCC CRL-11147 DMEM + 10% FBS NGTCBMEL003 WI 38 VA13 2RA Adherent Epithelial Human Malignant melanoma Skin Malignant melanoma ECACC DMEM + 10% FBS NGTCBNAS001 C666-1 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS002 CNE-2Z Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS003 CNE1 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS004 CNE1-lmp1 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS005 CNE2 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS006 HEP-2 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS007 HK-1 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS008 HNE1 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS009 HNE2 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS010 HNE2-LMP1 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS011 HNE3 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS012 HONE1 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBNAS013 SUNE-1 Adherent Epithelial Human Nasopharyngeal Carcinoma Nasopharynx Carcinoma RPMI1640 + 10% FBS NGTCBOVA001 A2780 Adherent Epithelial Human Ovarian Cancer Ovary Ovarian Cancer ECACC 93112519 RPMI1640 + 10% FBS NGTCBOVA002 Caov-3 Adherent Epithelial Human Ovarian Cancer Ovary Adenocarcinoma ATCC HTB-75 DMEM + 10% FBS NGTCBOVA003 MDAH2774 Adherent Epithelial Human Ovarian Cancer Ovary Ovarian Cancer ATCC CRL-10303 RPMI1640 + 10% FBS NGTCBOVA004 NIH:OVCAR3 Adherent Epithelial Human Ovarian Cancer Ovary Adenocarcinoma ATCC HTB-161 RPMI1640 + 20% FBS NGTCBOVA005 OAW42 Adherent Epithelial Human Ovarian Cancer Ovary Ovarian Cancer ECACC 85073102 DMEM + 2 mM Glutamine + 1 mM Sodium Pyruvate + 20 IU/l Bovine Insulin + 10% FBS NGTCBOVA006 OC 316 Adherent Epithelial Human Ovarian Cancer Ovary Adenocarcinoma ICLC HTL98014 RPMI1640 + 10% FBS NGTCBOVA007 OVCAR5 Adherent Epithelial Human Ovarian Cancer Ovary Ovarian Cancer RPMI1640 + 10% FBS NGTCBOVA008 OVCAR8 Adherent Epithelial Human Ovarian Cancer Ovary Ovarian Cancer RPMI1640 + 10% FBS NGTCBOVA009 SK-OV-3 Adherent Epithelial Human Ovarian Cancer Ovary Ovarian Cancer ATCC HTB-77 F12 + 10% FBS NGTCBPAN001 AsPC-1 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ATCC CRL-1682 RPMI1640 + 10% FBS NGTCBPAN002 BxPC-3 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ATCC CRL-1687 RPMI1640 + 10% FBS NGTCBPAN003 CFPAC-1 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ATCC IMEM + 10% FBS NGTCBPAN004 Capan-1 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ATCC HTB-79 RPMI1640 + 7% FBS NGTCBPAN005 Capan-2 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ATCC HTB-80 RPMI1640 + 10% FBS NGTCBPAN006 HPAC Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ATCC CRL-2119 DMEM/F12 + 10% FBS + 2-L-Glu + 0.02 mg/ml insulin + 0.005 mg/ml transferrin + 40 ng/ml hydrocortisone + 10 ng/ml EGF NGTCBPAN007 HPAF-II Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ATCC CRL-1997 MEM + 10% FBS NGTCBPAN008 HUP-T3 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma DSMZ ACC 259 MEM + 10% FBS + 1% NEAA + 1% Sodium Pyruvate NGTCBPAN009 Hs 766T Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ATCC HTB-134 DMEM + 10% FBS NGTCBPAN010 HuP-T4 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma MEM + 10% FBS + 2 mM L-Glu + 0.1 mM NEAA + 1 mM Na pyruvate NGTCBPAN011 KP-4 Adherent Epithelial Human Pancreatic Cancer Pancreas Pancreatic ductal cell carcinoma JCRB JCRB0182 IMDM + 20% FBS NGTCBPAN012 MIA PaCa-2 Adherent Epithelial Human Pancreatic Cancer Pancreas Carcinoma ATCC CRL-1420 DMEM + 10% FBS NGTCBPAN013 OAW28 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ECACC 85101601 DMEM + 10% FBS NGTCBPAN014 PANC-1 Adherent Epithelial Human Pancreatic Cancer Pancreas Epithelioid carcinoma ATCC CRL-1469 DMEM + 10% FBS NGTCBPAN015 PNT1A Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ECACC 95012614 DMEM + 10% FBS NGTCBPAN016 PSN1 Adherent Epithelial Human Pancreatic Cancer Pancreas ECACC 94060601 RPMI1640 + 10% FBS NGTCBPAN017 Panc-89 Adherent Epithelial Human Pancreatic Cancer Pancreas RPMI1640 + 10% FBS NGTCBPAN018 QGP-1 Adherent Epithelial Human Pancreatic Cancer Pancreas Pancreatic carcinoma of islet cell JCRB JCRB0183 RPMI1640 + 10% FBS NGTCBPAN019 SU86.86 Adherent Epithelial Human Pancreatic Cancer Pancreas RPMI1640 + 10% FBS NGTCBPAN020 SW1910 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma RPMI1640 + 10% FBS NGTCBPAN021 SW1990 Adherent Epithelial Human Pancreatic Cancer Pancreas Adenocarcinoma ATCC CRL-2172 L15 + 10% FBS NGTCBPAN022 T3M-4 Adherent Epithelial Human Pancreatic Cancer Pancreas RIKEN RCB1021 F10 + 10% FBS NGTCBPAN023 YAPC Adherent Epithelial Human Pancreatic Cancer Pancreas DSMZ ACC 382 RPMI1640 + 10% Hi FBS NGTCBPHA001 Detroit 562 Adherent Epithelial Human Pharynx Carcinoma Pharynx Carcinoma ATCC CCL-138 MEM + 1% NEAA + 1mM Sodium Pyruvate + 0.1% Lactalbumin hydrolysate + 10% FBS NGTCBPHA002 FaDu Adherent Epithelial Human Pharynx Carcinoma Pharynx Squamous cell carcinoma ATCC HTB-43 MEM + 10% FBS NGTCBPHA003 RWPE-1 Adherent Epithelial Human Pharynx Carcinoma Pharynx Carcinoma ATCC CRL-11609 RPMI1640 + 10% FBS NGTCBPRO001 22Rv1 Adherent Epithelial Human Prostate Cancer Prostate Carcinoma ATCC CRL-2505 RPMI1640 + 10% FBS NGTCBPRO002 A498 Adherent Epithelial Human Prostate Cancer Prostate Carcinoma RPMI1640 + 10% FBS NGTCBPRO003 CHP-212 Adherent Epithelial Human Prostate Cancer Prostate Neuroblastoma RPMI1640 + 10% FBS NGTCBPRO004 DU145 Adherent Epithelial Human Prostate Cancer Prostate Carcinoma ATCC HTB-81 RPMI1640 + 10% FBS NGTCBPRO005 LAPC4 Adherent Epithelial Human Prostate Cancer Prostate Carcinoma IMDM + 10% FBS NGTCBPRO006 LNCAP Adherent Fibroblast Human Prostate Cancer Prostate Carcinoma ATCC CRL-1740 85-90% RPMI 1640 + 10-15% FBS NGTCBPRO007 NB1 Adherent Fibroblast Human Prostate Cancer Prostate Carcinoma RPMI1640 + 10% FBS NGTCBPRO008 PC 346C Adherent Fibroblast Human Prostate Cancer Prostate Carcinoma RPMI1640 + 10% FBS NGTCBPRO009 PC-3 Adherent Epithelial Human Prostate Cancer Prostate Adenocarcinoma, Grade IV ATCC CRL-1435 F12 + 10% FBS NGTCBSKI001 A431 Adherent Epithelial Human Skin Cancer Skin, epidermis Epidermoid Carcinoma ATCC CRL-1555 alpha-MEM + 10% FBS NGTCBTHY001 8305C Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma ECACC 94090183 MEM + 10% FBS +   1% NEAA NGTCBTHY002 8505C Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma ECACC 94090184 MEM + 10% FBS +   1% NEAA NGTCBTHY003 ASH-3 Adherent Epithelial Human Thyroid Carcinoma Thyroid Anaplastic thyroid carcinoma JCRB JCRB1073 DMEM:RPMI 1640 (1:1) + 10% FBS NGTCBTHY004 B-CPAP Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma DSMZ ACC 273 90% RPMI 1640 + 10% h.i. FBS NGTCBTHY005 BHT-101 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma DMEM + 20% FBS + 0.5% human serum (+ 0.005 IU/ml TSH + 5 ug/ml human insulin) NGTCBTHY006 CAL-62 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma DSMZ ACC 448 90-95% DMEM + 5-10% h.i. FBS NGTCBTHY007 CGTH-W-1 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma RPMI1640 + 10% FBS NGTCBTHY008 FTC-133 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma ECACC 94060901 DMEM/F12 (1:1) + 10% FBS NGTCBTHY009 FTC-238 Adherent Epithelial Human Thyroid Carcinoma Thyroid Follicular thyroid carcinoma ECACC 94060902 DMEM/F12 (1:1) + 5% FBS NGTCBTHY010 HTC/C3 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma JCRB JCRB0164 DMEM + 10% FBS NGTCBTHY011 IHH-4 Adherent Epithelial Human Thyroid Carcinoma Thyroid Papillary thyroid carcinoma JCRB JCRB1079 DMEM/RPMI1640 (1:1) + 10% FBS NGTCBTHY012 KHM-5M Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma JCRB JCRB0148 RPMI1640 + 10% FBS NGTCBTHY013 KMH-2 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma JCRB JCRB1066 DMEM/RPMI1640 (1:1) + 10% FBS NGTCBTHY014 MB-1 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma RPMI1640 + 10% FBS NGTCBTHY015 ML-1 Adherent Epithelial Human Thyroid Carcinoma Thyroid Follicular thyroid carcinoma DMEM + 10-20% FBS + 2 mM L-Glutamine + 1 mM sodium pyruvate NGTCBTHY016 MZ-CRC-1 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma DMEM + 10% FBS NGTCBTHY017 NIM Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma DMEM + 10% FBS NGTCBTHY018 RO82-W-1 Adherent Epithelial Human Thyroid Carcinoma Thyroid Follicular thyroid carcinoma ECACC 92030502 DMEM/F12 (1:1) + 10% FBS NGTCBTHY019 S-117 Adherent Epithelial Human Thyroid Carcinoma Thyroid Sarcoma RPMI1640 + 10% FBS NGTCBTHY020 SNU-790 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma KCLB 00790 RPMI1640 + 10% FBS NGTCBTHY021 SNU-80 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma KCLB 00080 RPMI1640 + 10% FBS NGTCBTHY022 SW13 Adherent Epithelial Human Thyroid Carcinoma Adrenal gland/cortex Primary small cell carcinoma, Grade IV ATCC CCL-105 RPMI1640 + 10% FBS NGTCBTHY023 SW579 Adherent Epithelial Human Thyroid Carcinoma Thyroid Squamous cell carcinoma ATCC HTB-107 L15 + 10% FBS NGTCBTHY024 TCO-1 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma JCRB JCRB0239 DMEM + 10% FBS NGTCBTHY025 TPC-1 Adherent Epithelial Human Thyroid Carcinoma Thyroid Thyroid anaplastic carcinoma DMEM + 10% FBS NGTCBTHY026 TT Adherent Epithelial Human Thyroid Carcinoma Thyroid, medulla Carcinoma ATCC CRL-1803 F12K + 10% FBS NGTCBTHY027 TT2609-C02 Adherent Epithelial Human Thyroid Carcinoma Thyroid Follicular thyroid carcinoma RPMI1640 + 10% FBS 文章分类： 细胞库